Compare Direxion Daily S&P 500 Bull 3X Shares (SPXL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily S&P 500 Bull 3X Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? Direxion Daily S&P 500 Bull 3X Shares trades at $285.52 (market cap $7.34B), while Vir Biotechnology Inc. Common Stock trades at $10.53 (market cap $1.76B). The key difference: Direxion Daily S&P 500 Bull 3X Shares is far larger — about 4.2× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is more actively traded (2,764,948 versus 2,272,949). Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily S&P 500 Bull 3X Shares for 33 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SPXL | VIR | |
|---|---|---|
Market Cap | $7.34B | $1.76B |
Volume | 2,272,949 | 2,764,948 |
Sector | Leveraged / Inverse | Health |
52-Week High | $301.38 | $11.78 |
52-Week Low | $170.20 | $5.12 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | — | $1.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPXL, a leveraged ETF tracking the S&P 500, trades at $297.37 with no significant daily change. Technical indicators show a bullish trend supported by moving averages, though oscillators are neutral with the 6-day RSI at 75.74 suggesting potential overbought conditions. The stock is positioned near key support and resistance levels, with immediate support at $296 and resistance at $299. Recent news highlights mixed market sentiment, with expectations of profit growth deceleration in 2027 but historical seasonal patterns favoring year-end rallies.
The outlook for SPXL is cautiously optimistic, driven by the S&P 500's strong performance and AI-driven earnings growth. Key risks include market volatility, geopolitical tensions, and concentration in top holdings. Analyst consensus remains bullish, with the S&P 500 projected to reach 9,275 by September 2027, offering potential upside for leveraged exposure.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
